Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Berberine suppresses colon cancer cell proliferation by inhibiting the SCAP/SREBP-1 signaling pathway-mediated lipogenesis
Yunxin Liu, Weiwei Hua, Yao Li, et al.
Biochemical Pharmacology (2019) Vol. 174, pp. 113776-113776
Closed Access | Times Cited: 90

Showing 1-25 of 90 citing articles:

New opportunities and challenges of natural products research: When target identification meets single-cell multiomics
Yuyu Zhu, Zijun Ouyang, Haojie Du, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 11, pp. 4011-4039
Open Access | Times Cited: 241
Biological Activity of Berberine—A Summary Update
Anna Och, Rafał Podgórski, Renata Nowak
Toxins (2020) Vol. 12, Iss. 11, pp. 713-713
Open Access | Times Cited: 160
Plant isoquinoline alkaloids: Advances in the chemistry and biology of berberine
Sneha Singh, Nandini Pathak, Eram Fatima, et al.
European Journal of Medicinal Chemistry (2021) Vol. 226, pp. 113839-113839
Closed Access | Times Cited: 134
Anticancer Effects and Mechanisms of Berberine from Medicinal Herbs: An Update Review
Ruo-Gu Xiong, Siyu Huang, Si-Xia Wu, et al.
Molecules (2022) Vol. 27, Iss. 14, pp. 4523-4523
Open Access | Times Cited: 84
Targeting SREBP-1-Mediated Lipogenesis as Potential Strategies for Cancer
Qiushi Zhao, Xingyu Lin, Guan Wang
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 76
Berberine: A novel therapeutic strategy for cancer
Parisa Samadi, Parisa Sarvarian, Elham Gholipour, et al.
IUBMB Life (2020) Vol. 72, Iss. 10, pp. 2065-2079
Open Access | Times Cited: 80
Berberine, a Herbal Metabolite in the Metabolic Syndrome: The Risk Factors, Course, and Consequences of the Disease
Anna Och, Marek Och, Renata Nowak, et al.
Molecules (2022) Vol. 27, Iss. 4, pp. 1351-1351
Open Access | Times Cited: 46
Berberine a traditional Chinese drug repurposing: Its actions in inflammation-associated ulcerative colitis and cancer therapy
Cuipeng Zhu, Kaiqi Li, Xiaoxu Peng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 45
Apoptosis Induction, a Sharp Edge of Berberine to Exert Anti-Cancer Effects, Focus on Breast, Lung, and Liver Cancer
Yi Zhun Zhu, Na Xie, Yilu Chai, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 44
Berberine suppresses colorectal cancer by regulation of Hedgehog signaling pathway activity and gut microbiota
Qiang Sun, Han Yang, Maolun Liu, et al.
Phytomedicine (2022) Vol. 103, pp. 154227-154227
Closed Access | Times Cited: 43
The Impact of Oxidative Stress and AKT Pathway on Cancer Cell Functions and Its Application to Natural Products
Jun‐Ping Shiau, Ya-Ting Chuang, Jen‐Yang Tang, et al.
Antioxidants (2022) Vol. 11, Iss. 9, pp. 1845-1845
Open Access | Times Cited: 40
Effects and Mechanisms of Kaempferol in the Management of Cancers through Modulation of Inflammation and Signal Transduction Pathways
Ahmad Almatroudi, Khaled S. Allemailem, Wanian M. Alwanian, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8630-8630
Open Access | Times Cited: 38
Neuroprotective Properties of Berberine: Molecular Mechanisms and Clinical Implications
Erjie Tian, Gaurav Sharma, Chongshan Dai
Antioxidants (2023) Vol. 12, Iss. 10, pp. 1883-1883
Open Access | Times Cited: 33
An Updated Review on the Role of Nanoformulated Phytochemicals in Colorectal Cancer
Alakesh Das, Suman Adhikari, Dikshita Deka, et al.
Medicina (2023) Vol. 59, Iss. 4, pp. 685-685
Open Access | Times Cited: 28
The composition, pharmacological effects, related mechanisms and drug delivery of alkaloids from Corydalis yanhusuo
Jia-hua Feng, Kang Chen, Siyu Shen, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115511-115511
Open Access | Times Cited: 23
Current understanding and future prospects on Berberine for anticancer therapy
Anjana Goel
Chemical Biology & Drug Design (2023) Vol. 102, Iss. 1, pp. 177-200
Closed Access | Times Cited: 22
Jiao-tai-wan and its effective component-berberine improve diabetes and depressive disorder through the cAMP/PKA/CREB signaling pathway
Yueheng Tang, Yang Gao, Kexin Nie, et al.
Journal of Ethnopharmacology (2024) Vol. 324, pp. 117829-117829
Open Access | Times Cited: 12
Polyphenol-Loaded Nano-carriers for Breast Cancer Therapy: A Comprehensive Review
Asif Ahmad Bhat, Gaurav Gupta, Muhammad Afzal, et al.
BioNanoScience (2024) Vol. 14, Iss. 4, pp. 4219-4237
Closed Access | Times Cited: 11
Biologically active isoquinoline alkaloids covering 2019–2022
Dengtuo Wang, Lulu Qin, Chen-Xin Jing, et al.
Bioorganic Chemistry (2024) Vol. 145, pp. 107252-107252
Open Access | Times Cited: 10
A review of the berberine natural polysaccharide nanostructures as potential anticancer and antibacterial agents
Suliman Khan, Arif Hussain, Farnoosh Attar, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 146, pp. 112531-112531
Open Access | Times Cited: 51
Berberine alkaloids inhibit the proliferation and metastasis of breast carcinoma cells involving Wnt/β-catenin signaling and EMT
Lu-lu Dian, Zhaozhen Xu, Yanfang Sun, et al.
Phytochemistry (2022) Vol. 200, pp. 113217-113217
Closed Access | Times Cited: 29
Key events in cancer: Dysregulation of SREBPs
Yunkuo Li, Shouwang Wu, Xiaodong Zhao, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 21
The therapeutic effects of berberine for gastrointestinal cancers
Amirhossein Davoodvandi, Sahand Sadeghi, Seyed Mohammad Amin Alavi, et al.
Asia-Pacific Journal of Clinical Oncology (2023) Vol. 20, Iss. 2, pp. 152-167
Open Access | Times Cited: 17
Berberine: An inspiring resource for the treatment of colorectal diseases
Fang Cao, Weiyang Xia, Shengcheng Dai, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115571-115571
Open Access | Times Cited: 17
Berberine: Potential preventive and therapeutic strategies for human colorectal cancer
Yuqian Feng, Jiamin Lu, Jin Jiang, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 4
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top